首页|血栓抽吸术联合冠脉内注入重组人尿激酶原对急性ST段抬高型心肌梗死患者心肌灌注水平的改善效果

血栓抽吸术联合冠脉内注入重组人尿激酶原对急性ST段抬高型心肌梗死患者心肌灌注水平的改善效果

扫码查看
目的 探讨血栓抽吸术联合冠脉内注入重组人尿激酶原对急性ST段抬高型心肌梗死患者心肌灌注水平的改善效果。方法 选取2020年6月—2022年12月本院收治的80例急性ST段抬高型心肌梗死(STEMI)患者为研究对象,并将其随机分为两组,每组40例。对照组单用血栓抽吸术,观察组使用血栓抽吸术联合冠脉内注入重组人尿激酶原,对比两组的治疗效果、术后血流灌注指标、心肌损伤标志物及心功能指标、MACE及出血率。结果 两组术前TIMI分级无明显差异(P>0。05),观察组术后即刻TIMI分级中3级比例明显高于对照组(P<0。05);观察组术后1d的MBG 3级比例、ST段回落≥50%率高于对照组,术后NRP发生率低于对照组(P<0。05);观察组术后BNP、Mb、CK-MB、cTnⅠ均低于对照组,LVEF高于对照组(P<0。05);观察组再发心绞痛、再发STEMI、支架内血栓、靶血管重建、心脏性猝死等MACE明显低于对照组(P<0。05);两组TIMI大出血、TIMI小出血发生率相当(P>0。05)。结论 血栓抽吸术联合冠脉内注入重组人尿激酶原治疗STEMI的效果显著,能有效恢复心肌血流灌注,降低NRP率,改善心功能,减轻心肌损伤,且MACE低,出血风险较低,具有较高安全性。
Effect of Thrombus Aspiration Combined with Intracoronary Injection of Recombinant Human Prourokinase on Improving Myocardial Perfusion Levels of Patients with Acute ST Segment Elevation Myocardial Infarction
Objective To explore effect of thrombus aspiration combined with intracoronary injection of recombinant human prourokinase on improving myocardial perfusion levels of patients with acute ST segment elevation myocardial infarction.Methods The paper chose 80 patients with acute ST segment elevation myocardial infarction(STEMI)in our hospital from June 2020 to December 2022,and divided them into two groups randomly.Control group was treated with thrombus aspiration only,while observation group with thrombus aspiration combined with intracoronary injection of recombinant human prourokinase.Curative effect,postoperative blood flow perfusion indicators,myocardial injury markers and cardiac function indicators,MACE,and bleeding rate were compared between two groups.Results There was no significant difference in preoperative TIMI grading between two groups(P>0.05),proportion of grade 3 in immediate postoperative TIMI grading in observation group was significantly higher than control group(P<0.05).The proportion of MBG grade 3 and the rate of ST segment regression≥50%in observation group were higher than control group on the 1st day after surgery,incidence of postoperative NRP was lower than control group(P<0.05).Postoperative BNP,Mb,CK-MB,and cTn Ⅰ in observation group was lower than control group,while LVEF was higher than control group(P<0.05).The MACE of recurrent angina pectoris,recurrent STEMI,stent thrombosis,target vessel reconstruction,and sudden cardiac death in observation group was significantly lower than control group(P<0.05),and incidence of TIMI major bleeding and TIMI minor bleeding between two groups was comparable(P>0.05).Conclusion Combination of thrombus aspiration and intracoronary injection of recombinant human urokinase can achieve significant effect for STEMI,can restore myocardial blood flow perfusion,reduce NRP rate,improve heart function,and alleviate myocardial injury effectively.Moreover,it has low MACE and lower bleeding risk with high safety.

Acute ST segment elevation myocardial infarctionThrombosuctionCoronary injection of recombinant human prourokinaseEffectMyocardial perfusion

莫小燕

展开 >

广西合浦县人民医院 心血管内科,广西 合浦 536100

急性ST段抬高型心肌梗死 血栓抽吸术 冠脉内注入重组人尿激酶原 效果 心肌灌注

2024

智慧健康

智慧健康

ISSN:
年,卷(期):2024.10(18)